SI2607354T1 - Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino - Google Patents

Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino

Info

Publication number
SI2607354T1
SI2607354T1 SI201230075T SI201230075T SI2607354T1 SI 2607354 T1 SI2607354 T1 SI 2607354T1 SI 201230075 T SI201230075 T SI 201230075T SI 201230075 T SI201230075 T SI 201230075T SI 2607354 T1 SI2607354 T1 SI 2607354T1
Authority
SI
Slovenia
Prior art keywords
ivabradine
synthesis
pharmaceutically acceptable
addition salts
acceptable acid
Prior art date
Application number
SI201230075T
Other languages
English (en)
Inventor
Jean-Luc Renaud
Nicolas Pannetier
Sylvain Gaillard
Jean-Pierre Lecouve
Lucile Vaysse-Ludot
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47355960&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2607354(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SI2607354T1 publication Critical patent/SI2607354T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201230075T 2011-12-20 2012-12-19 Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino SI2607354T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1103934A FR2984320B1 (fr) 2011-12-20 2011-12-20 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP12197929.8A EP2607354B1 (fr) 2011-12-20 2012-12-19 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
SI2607354T1 true SI2607354T1 (sl) 2014-10-30

Family

ID=47355960

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230075T SI2607354T1 (sl) 2011-12-20 2012-12-19 Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino

Country Status (35)

Country Link
US (1) US8507668B2 (sl)
EP (1) EP2607354B1 (sl)
JP (1) JP5531084B2 (sl)
KR (1) KR101479986B1 (sl)
CN (1) CN103172567B (sl)
AR (1) AR089325A1 (sl)
AU (1) AU2012261583B2 (sl)
BR (1) BR102012032562A2 (sl)
CA (1) CA2798633C (sl)
CL (1) CL2012003579A1 (sl)
CY (1) CY1115620T1 (sl)
DK (1) DK2607354T3 (sl)
EA (1) EA021713B1 (sl)
ES (1) ES2516290T3 (sl)
FR (1) FR2984320B1 (sl)
GE (1) GEP20156245B (sl)
HK (1) HK1186734A1 (sl)
HR (1) HRP20140839T1 (sl)
JO (1) JO3083B1 (sl)
MA (1) MA34868B1 (sl)
MD (1) MD4275C1 (sl)
MX (1) MX2012014321A (sl)
MY (1) MY160928A (sl)
PE (1) PE20131325A1 (sl)
PL (1) PL2607354T3 (sl)
PT (1) PT2607354E (sl)
RS (1) RS53470B (sl)
SA (1) SA112340106B1 (sl)
SG (1) SG191498A1 (sl)
SI (1) SI2607354T1 (sl)
TW (1) TWI440628B (sl)
UA (1) UA111156C2 (sl)
UY (1) UY34508A (sl)
WO (1) WO2013093333A1 (sl)
ZA (1) ZA201209369B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
RU2473544C2 (ru) * 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
AU2010216150B2 (en) * 2009-02-17 2015-05-14 Mallinckrodt Llc Process for the reductive alkylation of normorphinans
ME00986B (me) * 2009-03-31 2012-06-20 Servier Lab Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Also Published As

Publication number Publication date
SG191498A1 (en) 2013-07-31
MX2012014321A (es) 2013-06-19
TW201331183A (zh) 2013-08-01
SA112340106B1 (ar) 2015-07-09
AR089325A1 (es) 2014-08-13
JP2013129656A (ja) 2013-07-04
EA201201571A1 (ru) 2013-07-30
PL2607354T3 (pl) 2014-10-31
RS53470B (en) 2014-12-31
CL2012003579A1 (es) 2014-09-05
HRP20140839T1 (hr) 2014-10-24
UA111156C2 (uk) 2016-04-11
PE20131325A1 (es) 2013-11-15
MD4275B1 (en) 2014-02-28
JP5531084B2 (ja) 2014-06-25
EA021713B1 (ru) 2015-08-31
KR101479986B1 (ko) 2015-01-08
UY34508A (es) 2013-06-28
TWI440628B (zh) 2014-06-11
EP2607354A1 (fr) 2013-06-26
HK1186734A1 (en) 2014-03-21
JO3083B1 (ar) 2017-03-15
WO2013093333A1 (fr) 2013-06-27
CA2798633C (fr) 2014-08-19
CN103172567B (zh) 2015-08-12
EP2607354B1 (fr) 2014-07-16
PT2607354E (pt) 2014-08-27
CN103172567A (zh) 2013-06-26
NZ604890A (en) 2014-03-28
KR20130071389A (ko) 2013-06-28
CA2798633A1 (fr) 2013-06-20
GEP20156245B (en) 2015-02-10
CY1115620T1 (el) 2017-01-04
AU2012261583B2 (en) 2014-01-16
ES2516290T3 (es) 2014-10-30
US8507668B2 (en) 2013-08-13
MD4275C1 (ro) 2014-09-30
DK2607354T3 (da) 2014-10-13
BR102012032562A2 (pt) 2013-11-12
AU2012261583A1 (en) 2013-07-04
MA34868B1 (fr) 2014-02-01
US20130158257A1 (en) 2013-06-20
MY160928A (en) 2017-03-31
FR2984320B1 (fr) 2013-11-29
FR2984320A1 (fr) 2013-06-21
ZA201209369B (en) 2013-08-28

Similar Documents

Publication Publication Date Title
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
PL2531286T3 (pl) Sposób syntezy metanolu
EP2740478A4 (en) PREPARATION FOR MAINTAINED RELEASE OF IVABRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
ZA201105172B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PL2241553T3 (pl) Sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie
ZA201404246B (en) Process for the preparation of(5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-1yl)-acetic acid
ZA201201329B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SI2736909T1 (sl) Proces za pripravo sitagliptina in njegovih farmacevtsko sprejemljivih soli
ZA201207397B (en) Process for the preparation of dexlansoprazole
HK1197069A1 (en) Methods for the synthesis and purification of deoxycholic acid
HK1169827A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1183488A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IN2012DE00289A (sl)
HU1000565D0 (en) Process for the preparation of pharmaceutically active compound and intermediers
IL225680A0 (en) Process for preparing 3-(6-amino-pyridin-3-yl)2-acrylic acid derivatives
HK1186733A1 (zh) 合成伊伐布雷定以及其與可藥用酸的加成鹽的新方法
PT2607354E (pt) Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico
HK1189892A1 (zh) 合成伊伐布雷定以及其可藥用酸加成鹽的新方法
PT2739610T (pt) Processo para o fabrico de ivabradina e de produtos intermédios para a sua síntese
EP2828251A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF SUNITINIB AND ITS ACID ADDITIONAL SALTS THEREOF
PL396871A1 (pl) Kwas naftaleno-1,4-difosfonowy, sposób wytwarzania kwasu naftaleno-1,4-difosfonowego i zastosowanie kwasu naftaleno-1,4-difosfonowego
PL393253A1 (pl) Nowe pochodne kwasu betulinowego i sposób ich otrzymywania
ZA201107792B (en) Process for the preparation of highly pure duloxetine hydrochloride
ZA200905507B (en) Improved process for the preparation of phenethylamine derivatives